| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 03/27/2008 | US20080075747 Acidic oil in water emulsion comprising allantoin; emulsifier system of an acidic anionic polylmer such as carbopol and an ethoxylated ether or an ethoxylated ester; cosmetics; storage stability; can further include a carbohydrate polymer that can be polygalactose or polyarabinose |
| 03/27/2008 | US20080075708 compounds having an anchoring domain that anchors the compound to the surface of target cell, and a therapeutic domain that can act extracellularly to prevent infection of the target cell by a pathogen, such as viruses; neuraminidase |
| 03/27/2008 | US20080075670 Admixing a pharmaceutical agent with a foam forming agent; introducing the mixture of into a dispensing device; metered dose, external auditory meatus |
| 03/26/2008 | EP1901780A2 Optical imaging contrast agents |
| 03/26/2008 | EP1556362B1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/26/2008 | CN100376291C Porous drug matrices and methods of manufacturing the same |
| 03/25/2008 | US7348448 Substituted phenyl esters; dementia |
| 03/25/2008 | US7348429 Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process |
| 03/25/2008 | US7348324 Cyclic amine compounds as CCR5 antagonists |
| 03/25/2008 | US7348305 Inhibitor of cardiac tachyarrhythmias |
| 03/25/2008 | US7348145 Multiplex polymerase chain reaction assays using consensus primers to amplify conserved regions of the DNA; hybridizing products onto substrate; chemiluminescence |
| 03/25/2008 | US7348002 peptides and monoclonal antibodies used as blocking agents, that disrupt the interaction between collagen and integrins; prophylaxis of inflammatory diseases |
| 03/25/2008 | US7347199 Pressurised metered dose inhalers (MDI) |
| 03/25/2008 | CA2343123C Active substance concentrate with formoterol, suitable for storage |
| 03/25/2008 | CA2315835C New crystalline form of 1-methyl-5-p-toluoylpyrrole-2-acetamidoacetic acid guaiacyl ester |
| 03/25/2008 | CA2203652C A method of down-regulating gene expression |
| 03/20/2008 | US20080070911 Ion channel modulating compounds and uses thereof |
| 03/20/2008 | US20080070881 Prostate Cancer Treatment |
| 03/20/2008 | US20080070858 Administering a natriuretic hormone peptide (NHP), or a nucleic acid sequence encoding NHP; respiratory system disorders |
| 03/20/2008 | US20080069842 Vaccines for Mycoplasma bovis and methods of use |
| 03/20/2008 | US20080069830 Isolation Dna; nucleotide sequences; genetic engineering |
| 03/19/2008 | EP1691813B1 Ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one, sterile, stable; closed system for packing the solution, process for eliminating alkaline residuals of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one crystals; |
| 03/19/2008 | EP1617955A4 Products for treating and preventing chronic diseases: eliminating the autoimmune triggers that underly chronic disease |
| 03/19/2008 | EP1578393A4 Primary rat hepatocyte toxicity modeling |
| 03/19/2008 | EP1453487B1 Pharmaceutical dosage form with multiple coatings |
| 03/19/2008 | CN101143898A Treatment of allergic conditions by use of IL-21 |
| 03/19/2008 | CN100375742C 4-oxoquinoline compounds and its use |
| 03/18/2008 | US7345181 Process for preparing prostaglandin derivatives and starting materials for the same |
| 03/18/2008 | US7345094 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer |
| 03/18/2008 | US7345053 Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use |
| 03/18/2008 | US7345050 Imidazo(1,2a)pyridine or pyrazolo(2,3a)pyridine derivatives; Alzheimer's and Parkinson's Disease; nervous system, brain, and psychological disorders |
| 03/18/2008 | US7345038 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 03/18/2008 | US7344656 Potassium monopersulfate particle surrounded by alcoholic gel, which is gelated via sodium polyacrylate |
| 03/18/2008 | CA2355776C Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents |
| 03/18/2008 | CA2298493C Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis |
| 03/13/2008 | US20080065112 ROBOTIC ARMS DLUs FOR PERFORMING SURGICAL TASKS |
| 03/13/2008 | US20080064854 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 03/13/2008 | US20080063794 Attaching a linker to the array of microelectrodes; adding a porogen and a polymerization solution, polymerizing to form a permeation layer attached to the surface of the array through the linker; removing the porogen; active electronic matrix devices for biological assays |
| 03/13/2008 | US20080063624 administering compounds which bind to the chemokine receptors, such as 1,1'-[1,4-phenylene-bis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane, optionally with colony stimulating factors, to effect regeneration of dead myocardium |
| 03/12/2008 | EP1897546A1 Combined compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid |
| 03/12/2008 | EP1691763A4 Cab molecules |
| 03/12/2008 | CN101141968A Treatment of a condition in a mammal with administration of compounds and methods of use |
| 03/12/2008 | CN100374551C Compositions comprising viruses and methods for concentrating virus preparations |
| 03/12/2008 | CN100374454C preparation method of 2-aminocarbonyl-9h-purine derivatives and intermediate thereof |
| 03/11/2008 | US7343224 Pharmaceutical compounding systems and methods and information management system for same |
| 03/11/2008 | US7342110 Polynucleotides, host cells and vectors for antibodies against leukemia CD 33 antigen |
| 03/11/2008 | US7342020 Effective against MMP 9 and 13; arthritis, atherosclerosis; synthesis |
| 03/11/2008 | US7342019 5, 6-diaryl-pyrazine-2-amide derivatives as CB1 antagonists |
| 03/11/2008 | US7341840 Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs |
| 03/11/2008 | US7341746 Chinese herbs extract |
| 03/11/2008 | US7341745 Tetrahydroberberine (THB), l-Tetrahydropalmatine (l-THP) and l-Stepholidine (l-SPD),isolated from Magnoliidae plants, decrease nicotine dependence, alcohol abuse, cocaine abuse and opiate dependence in humans. treatment for Parkinson's Alzheimers, |
| 03/11/2008 | US7341700 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 03/06/2008 | WO2005032482A8 Treatment of demyelinating autoimmune disease with modified ordered peptides |
| 03/06/2008 | US20080058325 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 03/06/2008 | US20080057519 Monoclonal antibody specific for b-cell chronic lymphocytic leukemia cell surface protein; diagnosing cell proliferative disorders of blood |
| 03/06/2008 | US20080057131 Glycolic acid-lactic acid copolymer matrix incorporated with a peptide drug and a corticosteroid; sustained release for two weeks; improved bioavailability |
| 03/06/2008 | US20080056988 [18f]-furanosylpurine derivatives and uses thereof |
| 03/05/2008 | EP1894921A2 9, 10-Alpha, Alpha-Oh-Taxane analogs and methods for production thereof |
| 03/05/2008 | EP1583504A4 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 03/05/2008 | EP1558290A4 Heat pasteurized liquids containing glucosamine |
| 03/05/2008 | CN101137326A Novel differential imaging method |
| 03/05/2008 | CN100372845C Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 03/04/2008 | US7338975 Lactams as modulators of chemokine receptor activity |
| 03/04/2008 | US7338957 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs |
| 03/04/2008 | US7338951 N-{2-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-4-yl}-N'-(1 H-indol-3-ylmethylene)-hydrazine; interleukin IL-12 overproduction-related disorder; antiinflammatory agent; autoimmune diseases: multiple sclerosis, sepsis, neuropathies, cirrhosis, hepatitis, diabetes, arthritis |
| 03/04/2008 | US7338947 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 02/28/2008 | WO2004100860A3 Stable liposomes for microencapsulation of animal venoms |
| 02/28/2008 | US20080051425 Vinorelbine derivatives |
| 02/28/2008 | US20080051407 These compounds lack a 1,4-bridging group as found in the ecteinascidins; and, have at the C-1 position a substituent selected from an amino or hydroxy group, optionally protected or derivatized; anticarcinogenic agents |
| 02/28/2008 | US20080051366 Aminosugar, glycosaminoglycan, and s-adenoslymethionine composition for the treatment and repair of connective tissue |
| 02/28/2008 | DE602004007105T2 Zusammensetzung zur behandlung von gastrointestinalen störungen Composition for the treatment of gastrointestinal disorders |
| 02/27/2008 | EP1575485A4 Methods for lightening skin and hair |
| 02/27/2008 | EP1501452A4 Injectable chondrocyte implant |
| 02/27/2008 | EP1268470B1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof |
| 02/27/2008 | EP1163000B1 Vaccine against antigens from bacteriae |
| 02/27/2008 | CN101130528A Process for the preparation of baccatin iii derivatives |
| 02/27/2008 | CN101130071A Vaccine |
| 02/27/2008 | CN100371323C Cyanopyrrolidine derivatives |
| 02/27/2008 | CN100370987C Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 02/26/2008 | US7335808 Destroying biological agents such as toxins and bacteria are provided wherein the substance to be destroyed is contacted with finely divided metal oxide or hydroxide nanocrystals and stabilization |
| 02/26/2008 | US7335751 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same |
| 02/26/2008 | US7335735 Intracellular estradiol binding protein (IEBP) for use as tool in identifying modulator for treatment and prevention of bone and cell proliferative disorders |
| 02/26/2008 | US7335649 3-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2-hydroxy-3'-(tetrazol-5-yl)biphenyl for treatment of thrombocytopenia; colony stimulating factors |
| 02/26/2008 | US7335335 Electrical measurement system; automatic; diagnosis of disease |
| 02/21/2008 | WO2005016247A3 Dna sequences, peptides, antibodies and vaccines for prevention and treatment of sars |
| 02/21/2008 | US20080044881 Advanced Indolinone Based Protein Kinase Inhibitors |
| 02/21/2008 | US20080044419 Treatment of T Cell Mediated Diseases by Inhibition of Fgfr3 |
| 02/21/2008 | US20080044363 Therapeutic Dental Composition |
| 02/20/2008 | EP1889838A1 Thrombopoietin mimetics |
| 02/20/2008 | EP1888590A2 Crystalline forms of a pyrrolotriazine compound |
| 02/20/2008 | EP1701687A4 Quinoa protein concentrate, production and functionality |
| 02/20/2008 | EP1408910B1 Stable cosmetic emulsion with polyamide gelling agent |
| 02/20/2008 | CN101125864A Heteroaromatic inhibitor for fructose-1,6-bisphosphatase |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/20/2008 | CN100369602C Improved skin composition |
| 02/19/2008 | US7332516 pathogenic form of amyloid beta polypeptides inhibitor; 2-(2-Fluoro-1,1'-biphenyl-4-yl)-2-methylpropanoic acid; nonsteroidal antiinflammatory agent, neuroprotectant, ; side effect reduction; cyclooxygenase inhibitor; Alzheimer's disease, cognition activator, neurogenerative disease |
| 02/19/2008 | US7332481 Thrombopoietin mimetics |
| 02/19/2008 | US7332156 Methods of treating wounds using IL-23 |
| 02/19/2008 | CA2231809C Body wash composition to impart conditioning properties to skin |
| 02/19/2008 | CA2173976C Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |